Search results for "Cancer"
Carcinoids contributed to recent increase in early-onset colorectal cancer rates
While colorectal carcinoid rates are increasing more quickly than colorectal adenocarcinoma rates in younger patients, adenocarcinomas are steadily increasing in almost all early-onset subgroups, including those in their 40s, a U.S. study found.
https://immattersacp.org/weekly/archives/2020/12/15/4.htm
15 Dec 2020
The ins and outs of insulin updates, new guidelines, and more
This month's issue addresses insulin, an updated cardiology guideline, and colorectal cancer screening.
https://immattersacp.org/archives/2024/02/the-ins-and-outs-of-insulin-updates-new-guidelines-and-more.htm
1 Feb 2024
GLP-1 receptor agonists associated with thyroid cancer
Patients taking a glucagon-like peptide-1 (GLP-1) receptor agonist had about one and a half times the risk of developing thyroid cancer compared to similar controls, according to an observational French study.
https://immattersacp.org/weekly/archives/2022/11/22/2.htm
22 Nov 2022
Taking action to bridge the physician shortage
Addressing the critical physician shortage requires a comprehensive strategy focused on empowering physicians, revamping training models, and reshaping incentives to prioritize patient-centered care.
https://immattersacp.org/archives/2024/04/taking-action-to-bridge-the-physician-shortage.htm
1 Apr 2024
Personal risk-based screening for lung cancer may be more cost-effective than recommended cutoffs
While risk-based screening strategies were robustly more cost-effective than the 2021 U.S. Preventive Services Task Force recommendation in a modeling study, whether the results will be replicable in complex real-world clinical practice remains uncertain, an editorial noted.
https://immattersacp.org/weekly/archives/2023/02/07/5.htm
7 Feb 2023
DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis
A meta-analysis compared three direct oral anticoagulants (DOACs) (apixaban, edoxaban, and rivaroxaban) to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
https://immattersacp.org/weekly/archives/2023/01/03/5.htm
3 Jan 2023
Ductal carcinoma in situ linked to higher long-term risks of breast cancer, mortality
Among women who had surgery for ductal carcinoma in situ, rates of developing invasive breast cancer later were lower with more intensive treatment and larger final surgical margins, an English study found.
https://immattersacp.org/weekly/archives/2020/06/02/4.htm
2 Jun 2020
MKSAP Quiz: Evaluation for intestinal metaplasia
A 40-year-old woman is evaluated for intestinal metaplasia found on recent upper endoscopy to assess postprandial pain. No ulcers were visualized but generalized erythema and irregular mucosal pattern was noted. Following biopsy specimens, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2024/01/30/3.htm
30 Jan 2024
Most incidental adrenal tumors are nonfunctioning, regardless of patient age, study finds
A Chinese study of a healthy community population found adrenal tumors in 1.6% of men and 1.2% of women. Prevalence increased with age from 0.2% in adults ages 18 to 25 years to 3.2% in adults older than age 65 years.
https://immattersacp.org/weekly/archives/2022/09/13/4.htm
13 Sep 2022
MKSAP Quiz: Follow-up visit for ovarian cancer
A 62-year-old woman is evaluated during a follow-up visit for recently diagnosed stage IIIA high-grade serous ovarian cancer. She underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy and completed six cycles of chemotherapy with cisplatin and paclitaxel. The patient's paternal aunt was diagnosed with breast cancer at age 52 years. Following a physical exam and lab studies, what is the most appropriate test to perform next?
https://immattersacp.org/weekly/archives/2019/01/29/3.htm
29 Jan 2019